Status:
COMPLETED
A Study of Two Approved Drugs in Patients With Osteoarthritis (0966-220)(COMPLETED)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Osteoarthritis
Eligibility:
All Genders
40+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to compare the safety and effectiveness of two approved drugs in the treatment of osteoarthritis of the knee.
Detailed Description
The duration of treatment is 6 weeks.
Eligibility Criteria
Inclusion
- Osteoarthritis of the knee which requires treatment with medication for pain relief
Exclusion
- Any known allergy to the study drugs
Key Trial Info
Start Date :
April 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2003
Estimated Enrollment :
413 Patients enrolled
Trial Details
Trial ID
NCT00092365
Start Date
April 1 2003
End Date
November 1 2003
Last Update
May 9 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.